NanoString, Accelerate, PacBio Shares Sharply up in September; Myriad, Sequenom Down | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of omics tools and molecular diagnostics firms bounced back in September, lifted by the broader market, after a sluggish August.

Overall, the GenomeWeb Daily News Index rose more than 4 percent in September, compared to August as 23 of the 30 firms in the Index saw their stocks increase month over month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.